JPRN-UMIN000033118已完成未知
Effect of once-weekly teriparatide for bone metabolism in primary osteoprosis patients. - Changes in markers by Weekly-Teriparatide.
Kindai University Hospital, Department of Orthopaedic surgery0 个研究点目标入组 30 人开始时间: 2018年6月23日最近更新:
适应症
试验速览
- 阶段
- 未知
- 状态
- 已完成
- 发起方
- 入组人数
- 30
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Observational
入排标准
- 年龄范围
- 60years-old 至 89years-old（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •Patients with diabetes, rheumatoid arthritis,respiratory,endocrinological and other disease and drug use that may affect bone metabolism were excluded.
研究者
相似试验
已完成
不适用
Effect of once-weekly teriparatide for bone metabolism in praimary osteoprosis patients.JPRN-UMIN000032090Kindai University Hospital Department of Orthopaedic surgery50
已完成
3 期
Bone Effects of Teriparatide Following AlendronateOsteoporosisNCT00191893Eli Lilly and Company66
进行中（未招募）
不适用
Teriparatide (PTH) and Bone Strength in Postmenopausal WomenOsteoporosisNCT01155245University Health Network, Toronto60
已完成
4 期
Bone Marker Changes With Teriparatide/Postmenopausal OsteoporosisOsteoporosis, Post-MenopausalNCT00532545Eli Lilly and Company45
招募中
Unknown
Safety and efficacy of twice-weekly teriparatide in hemodialysis patients with osteoporosisChronic Kidney DiseaseJPRN-jRCTs011230047ishio Saori50